TLGS Research · 2026-09-15 · brief

CDSCO September enforcement notice: compliance systems matter

Regulatory notice

Project and policy context

CDSCO’s public-notice list carries a 5 September 2026 item on coordinated action against illegal manufacture and distribution of misbranded drugs.

TLGS commercial assessment

For a legitimate healthcare network, this is a prompt to test supplier diligence, licensing records, traceability and escalation arrangements. The website should discuss business controls without repeating unverified allegations about particular companies.

Client priorities

• Review sourcing and licensing documentation within the organisation’s actual scope.
• Use the official notice and relevant regulator communications for any case-specific assessment.

Reference documents